The insulin signaling cascade in the muscle was evaluated in 26 morbid obese patients with NAFLD, of whom 43% had NASH, 59% insulin resistance and 26% type 2 diabetes mellitus. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.